Biography and Research Information
OverviewAI-generated summary
Narenraj Arulprakash's research focuses on the pharmacological effects of antiplatelet medications, particularly ticagrelor and clopidogrel, in patients with chronic kidney disease. His work has investigated the differential impact of these drugs on platelet aggregation and inflammatory markers in individuals with advanced renal insufficiency. Arulprakash also studies neurological complications and outcomes associated with various medical conditions, including COVID-19 and Wernicke's encephalopathy. His publications have examined the underutilization of stroke care and neurocritical care during the COVID-19 pandemic, as well as atypical presentations of neurological disorders. He has also documented cases of immune-related adverse events, such as myasthenia gravis induced by immune checkpoint inhibitors. Arulprakash has a publication record of 12 works, with an h-index of 5 and 82 total citations.
Metrics
- h-index: 5
- Publications: 12
- Citations: 83
Selected Publications
-
Case of Immune Checkpoint Inhibitor Induced Myasthenia Gravis (2024)
-
Atypical Clinical Presentations and Neuroimaging Findings of Wernicke Encephalopathy (P4-4.004) (2023)
-
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease (2023)
-
Cerebellar restricted diffusion in Wernicke’s encephalopathy (2022)
-
Continued Underutilization of stroke care during the COVID-19 pandemic (2021)
Collaboration Network
Top Collaborators
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Acute Encephalopathy is associated with worse outcomes in COVID-19 patients (2741)
- Cerebellar restricted diffusion in Wernicke’s encephalopathy
- Underutilization of Neuro Critical Care during the COVID-19 Pandemic (P9-7.001)
- Atypical Clinical Presentations and Neuroimaging Findings of Wernicke Encephalopathy (P4-4.004)
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (5057)
- Acute Encephalopathy is associated with worse outcomes in COVID-19 patients (2741)
- Underutilization of Neuro Critical Care during the COVID-19 Pandemic (P9-7.001)
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (5057)
- Acute Encephalopathy is associated with worse outcomes in COVID-19 patients (2741)
- Underutilization of Neuro Critical Care during the COVID-19 Pandemic (P9-7.001)
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (5057)
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (5057)
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (5057)
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (5057)
- Underutilization of Neuro Critical Care during the COVID-19 Pandemic (P9-7.001)
- Atypical Clinical Presentations and Neuroimaging Findings of Wernicke Encephalopathy (P4-4.004)
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (5057)
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (5057)
- Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke (5057)
- Acute Encephalopathy is associated with worse outcomes in COVID-19 patients (2741)
Similar Researchers
Based on overlapping research topics